Cargando…

Mutation of MUC16 Is Associated With Tumor Mutational Burden and Lymph Node Metastasis in Patients With Gastric Cancer

BACKGROUND: Lymph node metastasis (LNM) is a critical factor in determining the prognosis of gastric cancer (GC), but its underlying mechanism remains unclear. The tumor mutational burden (TMB) has recently been recognized as a biomarker for predicting prognosis and response to immune checkpoint inh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Fengxiang, Li, Xianzhe, Chen, Huaxian, Guo, Jianping, Xiong, Zhizhong, Yin, Shi, Jin, Longyang, Chen, Xijie, Luo, Dandong, Tang, Haijie, Mao, Chaobin, Lian, Lei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863212/ https://www.ncbi.nlm.nih.gov/pubmed/35211490 http://dx.doi.org/10.3389/fmed.2022.836892

Ejemplares similares

Lymphovascular or perineural invasion is associated with lymph node metastasis and survival outcomes in patients with gastric cancer
por: Zhang, Fengxiang, et al.
Publicado: (2023)

Clinicopathologic characteristics and prognosis of synchronous colorectal cancer: a retrospective study
por: Chen, Huaxian, et al.
Publicado: (2022)

Prognostic Value of N6-Methyladenosine-Related lncRNAs in Early-Stage Colorectal Cancer: Association With Immune Cell Infiltration and Chemotherapeutic Drug Sensitivity
por: Xiong, Zhizhong, et al.
Publicado: (2021)

A novel ceRNA-immunoregulatory axis based on immune cell infiltration in ulcerative colitis-associated colorectal carcinoma by integrated weighted gene co-expression network analysis
por: Yin, Shi, et al.
Publicado: (2022)

Identification and Validation of a Six Immune-Related Genes Signature for Predicting Prognosis in Patients With Stage II Colorectal Cancer
por: Li, Xianzhe, et al.
Publicado: (2021)

Elderly patients with stage II gastric cancer do not benefit from adjuvant chemotherapy
por: Guo, Jianping, et al.
Publicado: (2023)

Advanced lung cancer inflammation index predicts the outcomes of patients with non-metastatic gastric cancer after radical surgical resection
por: Chen, Huaxian, et al.
Publicado: (2023)

MUC4, MUC16, and TTN genes mutation correlated with prognosis, and predicted tumor mutation burden and immunotherapy efficacy in gastric cancer and pan‐cancer
por: Yang, Yue, et al.
Publicado: (2020)

Coexpression of MUC1 with p53 or MUC2 correlates with lymph node metastasis in colorectal carcinomas.
por: Jang, Kee Taek, et al.
Publicado: (2002)

Comprehensive characterization of MUC16 mutations in lung adenocarcinoma for immunotherapies and prognosis: An observational study
por: Liu, Tingjun, et al.
Publicado: (2023)

Association of MUC16 Mutation With Response to Immune Checkpoint Inhibitors in Solid Tumors
por: Zhang, Lei, et al.
Publicado: (2020)

A six-gene signature related with tumor mutation burden for predicting lymph node metastasis in breast cancer
por: Wang, Cenzhu, et al.
Publicado: (2021)

MUC4 and MUC1 Expression in Adenocarcinoma of the Stomach Correlates with Vessel Invasion and Lymph Node Metastasis: An Immunohistochemical Study of Early Gastric Cancer
por: Tamura, Yukihiro, et al.
Publicado: (2012)

Prognostic Value of MUC16 Mutation and Its Correlation with Immunity in Hepatocellular Carcinoma Patients
por: Liu, Bing, et al.
Publicado: (2022)

Triplet versus doublet neoadjuvant chemotherapy regimens for locally advanced gastric cancer: a propensity score matching analysis
por: Chen, Yonghe, et al.
Publicado: (2021)

Low mutation and neoantigen burden and fewer effector tumor infiltrating lymphocytes correlate with breast cancer metastasization to lymph nodes
por: Wang, Zhigang, et al.
Publicado: (2019)

MUC16 overexpression induced by gene mutations promotes lung cancer cell growth and invasion
por: Kanwal, Madiha, et al.
Publicado: (2018)

Bioinformatics Analysis Based on TCGA: MUC16 Mutation Correlates with Clinical Outcome in Gastric Cancer
por: Huang, Liang, et al.
Publicado: (2022)

Development and validation of a MUC16 mutation-associated immune prognostic model for lung adenocarcinoma
por: Liu, Honggang, et al.
Publicado: (2023)

Retracted: Prognostic Value of MUC16 Mutation and Its Correlation with Immunity in Hepatocellular Carcinoma Patients
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Genomic profiling and the impact of MUC19 mutation in hepatoid adenocarcinoma of the stomach
por: Zhu, Mengxuan, et al.
Publicado: (2022)

A Refined Staging Model for Resectable Pancreatic Ductal Adenocarcinoma Incorporating Examined Lymph Nodes, Location of Tumor and Positive Lymph Nodes Ratio
por: Song, Yunda, et al.
Publicado: (2018)

High mutation load, immune-activated microenvironment, favorable outcome, and better immunotherapeutic efficacy in melanoma patients harboring MUC16/CA125 mutations
por: Wang, Qinghua, et al.
Publicado: (2020)

CCL21-CCR7 promotes the lymph node metastasis of esophageal squamous cell carcinoma by up-regulating MUC1
por: Shi, Mo, et al.
Publicado: (2015)

Modified staging system of positive lymph nodes based nomogram in intrahepatic cholangiocarcinoma
por: Zhao, Chongyu, et al.
Publicado: (2023)

Metastatic lymph node ratio as an important prognostic factor in advanced gallbladder carcinoma with at least 6 lymph nodes retrieved
por: Wang, Junke, et al.
Publicado: (2023)

Sequencing Analysis of MUC6 and MUC16 Gene Fragments in Patients with Oropharyngeal Squamous Cell Carcinoma Reveals Novel Mutations: A Preliminary Study
por: Gaździcka, Jadwiga, et al.
Publicado: (2023)

Metallic expandable stents in the management of malignant tracheal stenosis due to esophageal cancer with lymph node metastasis
por: PENG, ZHAOHONG, et al.
Publicado: (2013)

Differential Expression of MUC12, MUC16, and MUC20 in Patients with Active and Remission Ulcerative Colitis
por: Yamamoto-Furusho, Jesús K., et al.
Publicado: (2015)

Implication of perineural invasion in patients with stage II gastric cancer
por: Luo, Dandong, et al.
Publicado: (2023)

Targeting Lymph Node Sinus Macrophages to Inhibit Lymph Node Metastasis
por: Hu, Junqing, et al.
Publicado: (2019)

Functional Consequences of Differential O-glycosylation of MUC1, MUC4, and MUC16 (Downstream Effects on Signaling)
por: Hanson, Ryan L., et al.
Publicado: (2016)

Comparison of the Transmembrane Mucins MUC1 and MUC16 in Epithelial Barrier Function
por: Gipson, Ilene K., et al.
Publicado: (2014)

Association of novel MUC16, MAP3K15 and ABCA1 mutation with giant congenital melanocytic nevus
por: Zhou, Renpeng, et al.
Publicado: (2022)

Overexpression of MUC16 predicts favourable prognosis in MUC16-mutant cervical cancer related to immune response
por: Wang, Hao, et al.
Publicado: (2020)

Why MUC16 mutations lead to a better prognosis: A study based on The Cancer Genome Atlas gastric cancer cohort
por: Huang, Yu-Jie, et al.
Publicado: (2021)

Concentrations of MUC16 and MUC5AC using three tear collection methods
por: Ablamowicz, Anna F., et al.
Publicado: (2017)

Surgical management of periampullary adenocarcinoma: defining an optimal prognostic lymph node stratification schema
por: He, Chaobin, et al.
Publicado: (2018)

BRAF and NRAS Mutations in Papillary Thyroid Carcinoma and Concordance in BRAF Mutations Between Primary and Corresponding Lymph Node Metastases
por: Fakhruddin, Najla, et al.
Publicado: (2017)

Higher axillary lymph node metastasis burden in breast cancer patients with positive preoperative node biopsy: may not be appropriate to receive sentinel lymph node biopsy in the post-ACOSOG Z0011 trial era
por: Liang, Yue, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3hafdld41k6rbirpqe9ihd34fr